Díaz MJR, López CRI, Lugo AJ, Rodríguez SC, Cuevas PI

Language: Spanish
References: 8
Page: 220-225
PDF size: 55.62 Kb.

ABSTRACT

Objective: To determine the main clinical, pathological and anatomical characteristics of the lesions of patients with initial diagnosis of larynx cancer; and the treatment, survival and causes of death of deceased patients treated at the National Oncology Institute of La Habana, Cuba, between 1966 and 1996. Material and methods: The clinical records of 630 patients with presumptive diagnosis of cancer of the larynx, deceased at the National Oncology Institute in Havana, between 1966 and 1996 were examined. Results: The supraglottic and glottic larynx assembled the largest amount of deceased patients with 238 and 208 cases respectively, which represents 70.79%. The largest evaluated group was included in the classification T3N0 with 158 patients that totaled 25.07%, followed by T1N0 with 118 patients, or 18.73%. Radiotherapy with Co60 was used in 398 patients, 63.17%, and surgery in 139 patients, 22.06%, the combination of radiotherapy and chemotherapy was used in only 21 cases (3.33%). The presence of multiple tumors was diagnosed in 73 patients, 11.58%, and the main locations were: lung, bladder, tonsil and prostate. A total of 222 patients, 35.23%, died during the first year after diagnosis, 61.11% in the first two years, and only 15.39% of the patients died after the 5th year. Recurrence diagnosis was performed during the first year in 421 (66.82%) and it reappeared after five years in only in 58 cases (9.20%). Conclusions: The largest number of patients died due to the primary tumor, 473 cases, and 33 patients died due to complications of surgical procedures.

REFERENCES

1. Díaz MJR, Rodríguez BO, Thompson LJL, Lugo AJ. Fallecidos por cáncer de la cavidad bucal. 30 años. Oncología 2001;24:207-212.

2. Díaz MJR, Rodríguez BO, Thompson LJL, Lugo AJ. Fallecidos por carcinoma faríngeo. 1966-1996. Oncología 2001;24:446-451.

3. Kowalsky LP, Batista M, Santos CR, Scopel A, Salcajolli JV, Torloni H. Prognostic factors in T3, N0–1 glottic and transglottic carcinoma. Arch Otolaryngol Head Neck Surg 1996;122:77-82.

4. Herranz J, Fernández M, Ramos S, Martínez VJ, Gavilán J, Gavilán C, y cols. Radioterapia en carcinoma glótico T1. Control local y sobrevida. Acta Otorrinolaringol Esp 2000;51:57-61.

5. Martínez-Berganza R, De Miguel GF, Fraile RJJ, Gil PP, Naya MJ. Mortalidad en cirugía por cáncer laríngeo. Acta Otorrinolaringol Esp 1998;49:206-210.

6. Díaz MJR. Carcinoma laríngeo: incidencia en el Instituto Nacional de Oncología en 10 años (1981-1990). Oncología SOLCA 1997;7:102-104.

7. Kajanti MJ, Holsti LR. Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the head and neck. Factors influencing local control and survival. Acta Oncol 1993;32:319-325.

8. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by site of origin of the tumours. Eur J Cancer 1998;34:2154-2161.